Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
02/22/2001 | WO2001012800A2 Method for the production of calendic acid, a fatty acid containing delta-8,10,12 conjugated double bonds and dimorphecolic acid, a fatty acid containing a 9-hydroxy group and delta-10,12 conjugated double bonds |
02/22/2001 | WO2001012792A1 Phytase enzymes, nucleic acids encoding phytase enzymes and vectors and host cells incorporating same |
02/22/2001 | WO2001012790A2 Isomerase proteins |
02/22/2001 | WO2001012786A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
02/22/2001 | WO2001012781A1 13 human colon and colon cancer associated proteins |
02/22/2001 | WO2001012780A1 Microorganism secreting out lipid and process for producing the lipid and lipid balls having the lipid encapsulating therein by using the microorganism |
02/22/2001 | WO2001012779A1 Preservation of bacterial cells at ambient temperatures |
02/22/2001 | WO2001012778A2 Flocculation of cell material |
02/22/2001 | WO2001012777A2 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
02/22/2001 | WO2001012776A2 18 human secreted proteins |
02/22/2001 | WO2001012775A2 25 human secreted proteins |
02/22/2001 | WO2001012673A1 Pgpcr-3 polypeptides and dna sequences thereof |
02/22/2001 | WO2001012672A2 Cytokine receptor common gamma chain like |
02/22/2001 | WO2001012671A1 Human tumor necrosis factor receptor tr16 |
02/22/2001 | WO2001012670A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
02/22/2001 | WO2001012665A2 Helical cytokine zalpha48 |
02/22/2001 | WO2001012664A2 Notch receptor ligands and uses thereof |
02/22/2001 | WO2001012663A2 Hematopoietic regulatory factors and methods of use thereof |
02/22/2001 | WO2001012662A2 Membrane associated proteins |
02/22/2001 | WO2001012648A1 Novel transcription factor, bp1 |
02/22/2001 | WO2001012646A1 Sialoadhesin factor-1 agonist and antagonist antibodies |
02/22/2001 | WO2000077179A3 Human poly(adp-ribose) polymerase 2 materials and methods |
02/22/2001 | WO2000071672A8 Utilization of microemulsions in fermentation processes |
02/22/2001 | WO2000063343A3 Bacterial culture |
02/22/2001 | WO2000061765A3 Lipoxygenase proteins and polynucleotides encoding the same |
02/22/2001 | WO2000061761A3 Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines |
02/22/2001 | WO2000058483A3 Protozoan expression system |
02/22/2001 | WO2000040614A3 Characterization of the soc/crac calcium channel protein family |
02/22/2001 | WO2000039297A3 Il-1 related polypeptides |
02/22/2001 | WO2000036107A3 Compositions and methods for therapy and diagnosis of ovarian cancer |
02/22/2001 | WO1999047553A3 Bacterial yeal family members as targets for antimicrobial drug design |
02/22/2001 | DE19939677A1 Inactivating bacteria that lack a cell wall, especially mycoplasmas, comprises applying a high hydrostatic pressure to a medium containing the bacteria |
02/22/2001 | DE19939578A1 New nucleic acid encoding hemocyanin, useful for gene therapy of tumors and for recombinant production of fusion proteins for vaccination |
02/22/2001 | DE19937719A1 New nucleic acid from phage phiCh1, used to create vectors for expressing proteins and polymers in halophilic Archaea |
02/22/2001 | DE10043662A1 Production of lignocellulosic fiber products, e.g. fiberboard, comprises treating the fibers with hydrolytic enzymes during or after disintegration to improve adhesion |
02/22/2001 | CA2733616A1 Process for the biological production of 1,3-propanediol with high titer |
02/22/2001 | CA2464845A1 Hematopoietic regulatory factors and methods of use thereof |
02/22/2001 | CA2385487A1 13 human colon and colon cancer associated proteins |
02/22/2001 | CA2385475A1 18 human secreted proteins |
02/22/2001 | CA2385431A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
02/22/2001 | CA2383922A1 Cytokine receptor common gamma chain like |
02/22/2001 | CA2383691A1 Human tumor necrosis factor receptor tr16 |
02/22/2001 | CA2382251A1 Methods for diagnosis and treatment of human diseases including hypertension |
02/22/2001 | CA2382239A1 Screening for udp-glucose: glycoprotein glucosyltransferase (uggt) activity |
02/22/2001 | CA2382148A1 25 human secreted proteins |
02/22/2001 | CA2382084A1 Phytase enzymes, nucleic acids encoding phytase enzymes and vectors and host cells incorporating same |
02/22/2001 | CA2382061A1 Preservation of bacterial cells at ambient temperatures |
02/22/2001 | CA2382048A1 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
02/22/2001 | CA2382019A1 Isomerase proteins |
02/22/2001 | CA2382018A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
02/22/2001 | CA2382015A1 Membrane associated proteins |
02/22/2001 | CA2381979A1 Pgpcr-3 polypeptides and dna sequences thereof |
02/22/2001 | CA2381863A1 Novel transcription factor, bp1 |
02/22/2001 | CA2381794A1 Helical cytokine zalpha48 |
02/22/2001 | CA2381427A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
02/22/2001 | CA2381316A1 Homogentisate-dioxygenase |
02/22/2001 | CA2380652A1 Flocculation of cell material |
02/22/2001 | CA2377662A1 Novel protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
02/22/2001 | CA2372991A1 Method for the production of calendic acid, a fatty acid containing delta-8,10,12 conjugated double bonds and related fatty acids having a modification at the delta-9 position |
02/22/2001 | CA2347094A1 Microorganisms that extracellulary secrete lipids and methods of producing lipid and lipid vesicles encapsulating lipids using said microorganisms |
02/21/2001 | EP1077263A1 Process for producing natural folded and secreted proteins by co-secretion of chaperones |
02/21/2001 | EP1077262A1 Process for the production of naturally folded and secreted proteins by co-secretion of molecular shaperones |
02/21/2001 | EP1077261A2 A process for the fermentative preparation of metabolic products and for the nucleotide sequences encoding sod |
02/21/2001 | EP1077256A1 Novel glutaminase, gene thereof and process for producing the same |
02/21/2001 | EP1077252A1 Microbial culture liquors containing microorganisms differing in characteristics and living in symbiosis and metabolites thereof, carriers and adsorbents containing the active components of the culture liquors and utilization of the same |
02/21/2001 | EP1077068A1 Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
02/21/2001 | EP1076720A2 NUCLEOTIDE SEQUENCES FOR DETECTING ENTEROHEMORRHAGIC $i(ESCHERICHIA COLI) (EHEC) |
02/21/2001 | EP1076711A2 Human apoptosis associated proteins |
02/21/2001 | EP1076710A2 Factors affecting tumor necrosis factor receptor releasing enzyme activity |
02/21/2001 | EP1076709A2 Sucrose phosphate synthase |
02/21/2001 | EP1076708A2 Method for the production of 1,3-propanediol by recombinant organisms comprising genes for vitamin b 12 transport |
02/21/2001 | EP1076707A1 PLASMID FOR GENE EXPRESSION IN $i(PICHIA CIFERRII) AND TRANSFORMATION METHOD USING THE SAME |
02/21/2001 | EP1076703A2 Il-17 homologous polypeptides and therapeutic uses thereof |
02/21/2001 | EP1076702A1 Human protease associated proteins |
02/21/2001 | EP1076700A2 Human nucleic acid sequences obtained from pancreas tumor tissue |
02/21/2001 | EP1076689A1 Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same |
02/21/2001 | EP1076662A2 Polyepitope carrier protein |
02/21/2001 | EP1076566A1 ATTENUATED MUTANTS OF $i(SALMONELLA) WHICH CONSTITUTIVELY EXPRESS THE Vi ANTIGEN |
02/21/2001 | CN2420287Y Spirulina cultivator |
02/21/2001 | CN1284998A A process for site-directed integration of multiple copies of gene in mould |
02/21/2001 | CN1284997A Modified deacetoxycephalosporin C synthase (DAOCS) and x-ray structure |
02/21/2001 | CN1284995A Tissue cement proteins from rhipicephalus appendiculatus |
02/21/2001 | CN1284994A Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria |
02/21/2001 | CN1284966A Novel G protein-coupled receptor |
02/21/2001 | CN1284965A Novel surface protein of i (neisseria meningitidis) |
02/21/2001 | CN1284882A Beta-lipotropin and uses thereof |
02/21/2001 | CN1284564A Method for production of D-arabitol, D-xyloketose and xylitol |
02/21/2001 | CN1284560A Fermentation prep. of metabolic products and nucleotide sequence of code sod gene |
02/21/2001 | CN1284559A Awete with rich selenium and other trace elements |
02/21/2001 | CN1284558A Psorospermial anthracin strain and its application method in biological herbicide |
02/21/2001 | CN1284379A Production process of salt algae powder and preparation of salt algae powder capsule |
02/21/2001 | CN1062309C Phytase and clone and expression of its gene |
02/21/2001 | CN1062307C Process for preparation of dry herginer bacterial culture-medium |
02/21/2001 | CN1062306C Microzyme Cu-metallothionein and its production |
02/20/2001 | US6191342 Transgenic mice expressing the HIK-ras 4B chimeric gene |
02/20/2001 | US6191267 Cloning and producing the N.BstNBI nicking endonuclease |
02/20/2001 | US6191261 Immunoglobulin that preferential binds a growth factor; for the diagnosis and treatment of cell proliferative defects; antiproliferative agents |
02/20/2001 | US6191258 Polypeptide which associates with symetric nucleotide sequences; for the artificial regulation of gene expression in plants |
02/20/2001 | US6190914 Methods for modulating metabolic pathways of micro-organisms and micro-organisms obtainable by said methods |
02/20/2001 | US6190909 TH2-specific gene |